BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 14561848)

  • 1. Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine.
    Luellen BA; Miller DB; Chisnell AC; Murphy DL; O'Callaghan JP; Andrews AM
    J Pharmacol Exp Ther; 2003 Dec; 307(3):923-31. PubMed ID: 14561848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurotoxin 2'-NH2-MPTP degenerates serotonin axons and evokes increases in hippocampal BDNF.
    Luellen BA; Szapacs ME; Materese CK; Andrews AM
    Neuropharmacology; 2006 Mar; 50(3):297-308. PubMed ID: 16288930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2'-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neurotransmission.
    Andrews AM; Murphy DL
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1432-9. PubMed ID: 8263805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2'-NH(2)-MPTP [1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine] depletes serotonin and norepinephrine in rats: a comparison with 2'-CH(3)-MPTP [1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine].
    Unger EL; Mazzola-Pomietto P; Murphy DL; Andrews AM
    J Pharmacol Exp Ther; 2002 Nov; 303(2):527-33. PubMed ID: 12388632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.
    Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
    Glia; 2003 May; 42(3):307-13. PubMed ID: 12673835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF-2 in the MPTP model of Parkinson's disease: effects on astroglial cells.
    Otto D; Unsicker K
    Glia; 1994 May; 11(1):47-56. PubMed ID: 8070894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MAP kinase cascade is activated prior to the induction of gliosis in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of dopaminergic neurotoxicity.
    O'Callaghan JP; Martin PM; Mass MJ
    Ann N Y Acad Sci; 1998 May; 844():40-9. PubMed ID: 9668663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic mice with high levels of superoxide dismutase activity are protected from the neurotoxic effects of 2'-NH2-MPTP on serotonergic and noradrenergic nerve terminals.
    Andrews AM; Ladenheim B; Epstein CJ; Cadet JL; Murphy DL
    Mol Pharmacol; 1996 Dec; 50(6):1511-9. PubMed ID: 8967972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of membrane and vesicular monoamine transporters in the neurotoxic and hypothermic effects of 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH(2)-MPTP).
    Numis AL; Unger EL; Sheridan DL; Chisnell AC; Andrews AM
    Mol Pharmacol; 2004 Sep; 66(3):718-27. PubMed ID: 15322265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained depletion of cortical and hippocampal serotonin and norepinephrine but not striatal dopamine by 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH2-MPTP): a comparative study with 2'-CH3-MPTP and MPTP.
    Andrews AM; Murphy DL
    J Neurochem; 1993 Mar; 60(3):1167-70. PubMed ID: 8094744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late onset loss of hippocampal 5-HT and NE is accompanied by increases in BDNF protein expression in mice co-expressing mutant APP and PS1.
    Szapacs ME; Numis AL; Andrews AM
    Neurobiol Dis; 2004 Aug; 16(3):572-80. PubMed ID: 15262269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF-2-mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells.
    Otto D; Unsicker K
    J Neurosci Res; 1993 Mar; 34(4):382-93. PubMed ID: 8097265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of brain-derived neurotrophic factor in nestin-expressing astroglial cells in the neostriatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
    Chen LW; Hu HJ; Liu HL; Yung KK; Chan YS
    Neuroscience; 2004; 126(4):941-53. PubMed ID: 15207328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences on MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in C57BL/6 mice.
    Ookubo M; Yokoyama H; Kato H; Araki T
    Mol Cell Endocrinol; 2009 Nov; 311(1-2):62-8. PubMed ID: 19631714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrethroid and organophosphate insecticide exposure in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease: an immunohistochemical analysis of tyrosine hydroxylase and glial fibrillary acidic protein in dorsolateral striatum.
    Dodd CA; Klein BG
    Toxicol Ind Health; 2009 Feb; 25(1):25-39. PubMed ID: 19318502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
    Aoki E; Yano R; Yokoyama H; Kato H; Araki T
    Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.
    Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL
    Neurotoxicology; 2004 Sep; 25(5):761-9. PubMed ID: 15288507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment.
    Knyihár-Csillik E; Csillik B; Pákáski M; Krisztin-Péva B; Dobó E; Okuno E; Vécsei L
    Neuroscience; 2004; 126(4):899-914. PubMed ID: 15207325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective role of melatonin in domoic acid-induced neuronal damage in the hippocampus of adult rats.
    Ananth C; Gopalakrishnakone P; Kaur C
    Hippocampus; 2003; 13(3):375-87. PubMed ID: 12722978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X; Baumann MH; Xu H; Rothman RB
    Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.